Xin Leng Selected Research

Xin Leng Research Topics

6	Neoplasms (Cancer) 01/2024 - 01/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2020
1	Carcinoma (Carcinomatosis) 01/2024
1	Colonic Neoplasms (Colon Cancer) 01/2024
1	COVID-19 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Pathologic Processes 01/2022
1	Heart Failure 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 03/2020
1	Branchiootic syndrome 02/2019
1	Branchiootic Syndrome 2 02/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 10/2018
1	Inflammation (Inflammations) 03/2018

2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2024
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021 - 02/2019
1	Messenger RNA (mRNA)IBA 01/2024
1	ApolipoproteinsIBA 01/2024
1	Apolipoproteins E (ApoE)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	Sincalide FDA Link 01/2024
1	CopperIBA 01/2022
1	MetalsIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 02/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021
1	rhodamine BIBA 02/2019
1	salicylaldehydeIBA 02/2019
1	RhodaminesIBA 02/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	polyphyllin IIIBA 01/2019
1	SaponinsIBA 01/2019
1	Emodin (Archin)IBA 10/2018
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 09/2018
1	LipopolysaccharidesIBA 03/2018
1	heterophyllin BIBA 03/2018
1	triptolideIBA 01/2018

3	Therapeutics 01/2019 - 09/2018
2	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 03/2020 - 01/2019
1	Cardiac Rehabilitation 01/2023
1	Immunotherapy 02/2021
1	Stem Cell Transplantation 03/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019